全文获取类型
收费全文 | 244184篇 |
免费 | 15810篇 |
国内免费 | 993篇 |
专业分类
耳鼻咽喉 | 2707篇 |
儿科学 | 6329篇 |
妇产科学 | 4672篇 |
基础医学 | 30795篇 |
口腔科学 | 4669篇 |
临床医学 | 24771篇 |
内科学 | 50766篇 |
皮肤病学 | 3480篇 |
神经病学 | 24549篇 |
特种医学 | 10704篇 |
外国民族医学 | 18篇 |
外科学 | 38647篇 |
综合类 | 2555篇 |
现状与发展 | 1篇 |
一般理论 | 181篇 |
预防医学 | 16822篇 |
眼科学 | 5865篇 |
药学 | 16225篇 |
1篇 | |
中国医学 | 341篇 |
肿瘤学 | 16889篇 |
出版年
2023年 | 1281篇 |
2022年 | 1036篇 |
2021年 | 5427篇 |
2020年 | 3127篇 |
2019年 | 5176篇 |
2018年 | 6310篇 |
2017年 | 4642篇 |
2016年 | 5092篇 |
2015年 | 5956篇 |
2014年 | 8632篇 |
2013年 | 11595篇 |
2012年 | 17876篇 |
2011年 | 18559篇 |
2010年 | 10356篇 |
2009年 | 9535篇 |
2008年 | 16360篇 |
2007年 | 17163篇 |
2006年 | 16697篇 |
2005年 | 16535篇 |
2004年 | 15581篇 |
2003年 | 14210篇 |
2002年 | 13642篇 |
2001年 | 2293篇 |
2000年 | 1827篇 |
1999年 | 2345篇 |
1998年 | 2860篇 |
1997年 | 2266篇 |
1996年 | 1989篇 |
1995年 | 1805篇 |
1994年 | 1576篇 |
1993年 | 1527篇 |
1992年 | 1141篇 |
1991年 | 1070篇 |
1990年 | 931篇 |
1989年 | 867篇 |
1988年 | 816篇 |
1987年 | 751篇 |
1986年 | 774篇 |
1985年 | 823篇 |
1984年 | 989篇 |
1983年 | 873篇 |
1982年 | 1072篇 |
1981年 | 998篇 |
1980年 | 865篇 |
1979年 | 586篇 |
1978年 | 572篇 |
1977年 | 512篇 |
1976年 | 447篇 |
1975年 | 358篇 |
1974年 | 375篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
Emmi Helle Aldo Córdova-Palomera Tiina Ojala Priyanka Saha Praneetha Potiny Stefan Gustafsson Erik Ingelsson Michael Bamshad Deborah Nickerson Jessica X. Chong University of Washington Center for Mendelian Genomics Euan Ashley James R. Priest 《Genetic epidemiology》2019,43(2):215-226
Loss of function variants in NOTCH1 cause left ventricular outflow tract obstructive defects (LVOTO). However, the risk conferred by rare and noncoding variants in NOTCH1 for LVOTO remains largely uncharacterized. In a cohort of 49 families affected by hypoplastic left heart syndrome, a severe form of LVOTO, we discovered predicted loss of function NOTCH1 variants in 6% of individuals. Rare or low-frequency missense variants were found in 16% of families. To make a quantitative estimate of the genetic risk posed by variants in NOTCH1 for LVOTO, we studied associations of 400 coding and noncoding variants in NOTCH1 in 1,085 cases and 332,788 controls from the UK Biobank. Two rare intronic variants in strong linkage disequilibrium displayed significant association with risk for LVOTO amongst European-ancestry individuals. This result was replicated in an independent analysis of 210 cases and 68,762 controls of non-European and mixed ancestry. In conclusion, carrying rare predicted loss of function variants in NOTCH1 confer significant risk for LVOTO. In addition, the two intronic variants seem to be associated with an increased risk for these defects. Our approach demonstrates the utility of population-based data sets in quantifying the specific risk of individual variants for disease-related phenotypes. 相似文献
94.
95.
Mohamed E. Salem J. Nicholas Bodor Alberto Puccini Joanne Xiu Richard M. Goldberg Axel Grothey W. Michael Korn Anthony F. Shields William M Worrilow Edward S. Kim Heinz-Josef Lenz John L. Marshall Michael J. Hall 《International journal of cancer. Journal international du cancer》2020,147(10):2948-2956
Microsatellite instability-high (MSI-H) and tumor mutational burden (TMB) are predictive biomarkers for immune-checkpoint inhibitors (ICIs). Still, the relationship between the underlying cause(s) of MSI and TMB in tumors remains poorly defined. We investigated associations of TMB to mismatch repair (MMR) protein expression patterns by immunohistochemistry (IHC) and MMR mutations in a diverse sample of tumors. Hypothesized differences were identified by the protein/gene affected/mutated and the tumor histology/primary site. Overall, 1057 MSI-H tumors were identified from the 32 932 tested. MSI was examined by NGS using 7000+ target microsatellite loci. TMB was calculated using only nonsynonymous missense mutations sequenced with a 592-gene panel; a subset of MSI-H tumors also had MMR IHC performed. Analyses examined TMB by MMR protein heterodimer impacted (loss of MLH1/PMS2 vs. MSH2/MSH6 expression) and gene-specific mutations. The sample was 54.6% female; mean age was 63.5 years. Among IHC tested tumors, loss of co-expression of MLH1/PMS2 was more common (n = 544/705, 77.2%) than loss of MSH2/MSH6 (n = 81/705, 11.5%; P < .0001), and was associated with lower mean TMB (MLH1/PMS2: 25.03 mut/Mb vs MSH2/MSH6 46.83 mut/Mb; P < .0001). TMB also varied by tumor histology: colorectal cancers demonstrating MLH1/PMS2 loss had higher TMBs (33.14 mut/Mb) than endometrial cancers (20.60 mut/Mb) and other tumors (25.59 mut/Mb; P < .0001). MMR gene mutations were detected in 42.0% of tumors; among these, MSH6 mutations were most common (25.7%). MSH6 mutation patterns showed variability by tumor histology and TMB. TMB varies by underlying cause(s) of MSI and tumor histology; this heterogeneity may contribute to differences in response to ICI. 相似文献
96.
Babiker Hani M. Milhem Mohammed Aisner Joseph Edenfield William Shepard Dale Savona Michael Iyer Swaminathan Abdelrahim Maen Beach C. L. Skikne Barry Laille Eric Tsai Kao-Tai Ho Thai 《Cancer chemotherapy and pharmacology》2020,85(3):621-626
Cancer Chemotherapy and Pharmacology - CC-486 is an oral formulation of azacitidine that allows for extended dosing schedules to prolong azacitidine exposure to malignant cells and maximize... 相似文献
97.
98.
99.
Mahwash Kassi Venkateshwar Polsani Robert C. Schutt Solomon Wong Faisal Nabi Michael J. Reardon Dipan J. Shah 《The Journal of thoracic and cardiovascular surgery》2019,157(5):1912-1922.e2
Background
The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning.Methods
This was a prospective cohort study of 130 patients who underwent cardiac magnetic resonance imaging for evaluation of a suspected cardiac mass. After excluding thrombi and tumors without definitive diagnosis, 66 tumors were evaluated for morphologic features and tissue composition.Results
Of the 66 patients, 39 (59.0%) had malignant tumors and 27 (41.0%) had benign tumors. Patients with malignant tumors were younger when compared with those with benign tumors (age 51 years [42.8-60.0] vs 65 years [60.0-71.0] median). Malignant tumors more often demonstrated tumor invasion (69% vs 0% P < .001) and were more often associated with pericardial effusion (41% vs 7.4% P = .004). Presence of first-pass perfusion (100% vs 33% P < .001) and late gadolinium enhancement (100% vs 59.2%, P < .001) were significantly higher in malignant tumors. In logistic regression modeling, tumor invasion (P < .001) and first-pass perfusion (P < .001) were independently associated with malignancy. Furthermore, using classification and regression tree analysis, we developed a decision tree algorithm to help differentiate benign from malignant tumors (diagnostic accuracy ~90%). The algorithm-weighted cost of misclassifying a malignant tumor as benign was twice that of classifying a benign tumor as malignant.Conclusions
Our study demonstrates that cardiac magnetic resonance imaging is a useful noninvasive method for differentiating malignant from benign cardiac tumors. Tumor size, invasion, and first-pass perfusion were useful imaging characteristics in differentiating benign from malignant tumors. 相似文献100.
Der Freie Zahnarzt - Rechtstipp. Für angebliche Behandlungs- und Aufklärungsfehler bleiben die Zivilgerichte auch bei Kostenerstattung zuständig. Eine kuriose, wiewohl wichtige... 相似文献